FDA nod for Aurobindo's Sildenafil injection
25 May 2015 | News | By BioSpectrum Bureau
FDA nod for Aurobindo's Sildenafil injection
Sildenafil is a generic version of Pfizer's Revatio injection
Aurobindo Pharma has announced that it has received approval from the US Food and Drug Administration ( US FDA) to manufacture and market Sildenafil injection.
Sildenafil injection is a generic version of Pfizer's Revatio injection.
The injection is indicated for the treatment of adult patients with pulmonary arterial hypertension who are temporarily unable to take oral therapy, but are otherwise clinically and haemodynamically stable.
